[go: up one dir, main page]

CH533095A - Verfahren zur Herstellung von Androstan-Verbindungen - Google Patents

Verfahren zur Herstellung von Androstan-Verbindungen

Info

Publication number
CH533095A
CH533095A CH955170A CH955170A CH533095A CH 533095 A CH533095 A CH 533095A CH 955170 A CH955170 A CH 955170A CH 955170 A CH955170 A CH 955170A CH 533095 A CH533095 A CH 533095A
Authority
CH
Switzerland
Prior art keywords
production
androstane compounds
androstane
compounds
Prior art date
Application number
CH955170A
Other languages
English (en)
Inventor
Campbell J Allan
Claude Babcock John
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CH533095A publication Critical patent/CH533095A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J53/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
CH955170A 1969-07-29 1970-06-24 Verfahren zur Herstellung von Androstan-Verbindungen CH533095A (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84587769A 1969-07-29 1969-07-29

Publications (1)

Publication Number Publication Date
CH533095A true CH533095A (de) 1973-01-31

Family

ID=25296306

Family Applications (1)

Application Number Title Priority Date Filing Date
CH955170A CH533095A (de) 1969-07-29 1970-06-24 Verfahren zur Herstellung von Androstan-Verbindungen

Country Status (8)

Country Link
US (1) US3580937A (de)
BE (1) BE754111A (de)
CH (1) CH533095A (de)
DE (1) DE2035738A1 (de)
FR (1) FR2059572B1 (de)
GB (1) GB1279186A (de)
IL (1) IL34974A (de)
NL (1) NL7009586A (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656621A (en) * 1983-08-02 1997-08-12 Research Corporation Tech., Inc. Steroids useful as anti-cancer and anti-obesity agents
US5804576A (en) * 1983-08-02 1998-09-08 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17-ones and 5-androstan-17-ones
US5714481A (en) * 1983-08-02 1998-02-03 Research Corporation Technologies, Inc. Derivatives of 5-androsten-17 ones and 5-androstan-17-ones
EP0133995B1 (de) * 1983-08-02 1992-04-15 Research Corporation Technologies, Inc. Steroide und diese enthaltende therapeutische Zusammensetzungen
US5028631A (en) * 1987-11-25 1991-07-02 Schwartz Arthur G Homoandrostan-17-one and homoandrosten-17-ones
US5001119A (en) * 1987-11-25 1991-03-19 Schwartz Arthur G 16-substituted androstanes and 16-substituted androstenes
US4898694A (en) * 1987-11-25 1990-02-06 Schwartz Arthur G 17-Hydroxy-steroids
US5175154A (en) * 1987-11-25 1992-12-29 Research Corporation Technologies, Inc. 5 α-pregnan-20-ones and 5-pregnen-20-ones and related compounds
CA2669753C (en) 1999-09-30 2012-06-26 Hollis-Eden Pharmaceuticals, Inc. Therapeutic treatment of androgen receptor driven conditions
AU2012323888A1 (en) 2011-10-14 2014-05-29 Sage Therapeutics, Inc. 3,3 disubstituted 19-nor pregnane compounds, compositions, and uses thereof
RU2681835C2 (ru) 2012-01-23 2019-03-13 Сейдж Терапьютикс, Инк. Лекарственные формы нейроактивных стероидов и способы лечения нарушений цнс
IL294306B2 (en) 2012-08-21 2024-01-01 Sage Therapeutics Inc Methods of treating epilepsy or status epilepticus
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
BR112015026380A8 (pt) 2013-04-17 2019-12-31 Sage Therapeutics Inc esteróides de c21-n-pirazolil 19-nor c3,3-dissubstituídos e métodos de uso destes
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
AU2014290400B2 (en) 2013-07-19 2019-12-05 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3488852B1 (de) 2013-08-23 2020-10-28 Sage Therapeutics, Inc. Neuroaktive steroide, zusammensetzungen und verwendungen davon
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
AU2015331597B2 (en) 2014-10-16 2020-04-30 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
CN117024502A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
EP3719029A1 (de) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Zusammensetzungen zur induzierung von sedation
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
KR20220084418A (ko) 2016-03-08 2022-06-21 세이지 테라퓨틱스, 인크. 신경활성 스테로이드, 조성물, 및 그의 용도
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス, インコーポレイテッド C7、c12、およびc16置換神経刺激性ステロイドおよびそれらの使用方法
NZ749664A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc

Also Published As

Publication number Publication date
IL34974A (en) 1974-06-30
FR2059572A1 (de) 1971-06-04
US3580937A (en) 1971-05-25
DE2035738A1 (de) 1971-02-11
IL34974A0 (en) 1970-09-17
GB1279186A (en) 1972-06-28
FR2059572B1 (de) 1974-08-23
BE754111A (fr) 1971-01-29
NL7009586A (de) 1971-02-02

Similar Documents

Publication Publication Date Title
CH533095A (de) Verfahren zur Herstellung von Androstan-Verbindungen
CH544093A (de) Verfahren zur Herstellung von O-Acyl-lysergolen
AT291933B (de) Verfahren zur Herstellung von Magnesium-Alkohol-Verbindungen
AT305417B (de) Verfahren zur Herstellung von Schaltkreisen
AT295743B (de) Verfahren zur Herstellung von Bleomycinen
CH543553A (de) Verfahren zur Herstellung von Poly-amid-imid-estern
AT299141B (de) Verfahren zur Herstellung von 2-Äthylhexanol
AT306715B (de) Verfahren zur Herstellung von ω-Lactamen
AT308075B (de) Verfahren zur Herstellung von Monochlorbenzaldehyden
AT313878B (de) Verfahren zur Herstellung von Alkylophenolen
AT300840B (de) Verfahren zur Herstellung von Organo-H-silanen
CH543487A (de) Verfahren zur Herstellung von Adamantylharnstoffen
CH544808A (de) Verfahren zur Herstellung von Negamycin
AT310769B (de) Verfahren zur Herstellung von ɛ-Caprolacton
AT324546B (de) Verfahren zur herstellung von aminopenicillinen
AT307418B (de) Verfahren zur Herstellung von neuem 8-Cyano-5-octanolid
CH497425A (de) Verfahren zur Herstellung von B-Picolin
CH544758A (de) Verfahren zur Herstellung von Lysergolen
CH504530A (de) Verfahren zur Herstellung von Cytidin-diphosphat-cholin
AT298431B (de) Verfahren zur Herstellung von Isopren
AT303377B (de) Verfahren zur Herstellung von Polyolefinen
AT301769B (de) Verfahren zur Herstellung von neuen 21-Halogensteroiden
AT314096B (de) Verfahren zur Herstellung von substituierten Cobamiden
CH523774A (de) Verfahren zur Herstellung von Pressteilen
AT303960B (de) Verfahren zur herstellung von alpha-aminobenzylpenicillin

Legal Events

Date Code Title Description
PL Patent ceased